June 6, 2023
Kaken Pharmaceutical said on June 2 that it has concluded an exclusive distribution agreement in South Korea with local partner Dong-Wha Pharm for its primary axillary hyperhidrosis treatment Ecclock (sofpironium bromide). Under the deal, signed on June 1, the Japanese...read more